Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ULTRA-COVID: Low-Dose Lung RT for COVID-19
NCT04394182Suspended
- Sponsor
- Fundación GenesisCare
- Start
- Apr 2020
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Fundación GenesisCare. Primary endpoints: Oxygen Therapy Status at Day 2 and Oxygen Saturation (Sat02) at Day 2. Started Apr 2020; status: suspended.
Beyond the preview
Go deeper on NCT04394182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04394182.